Abstract
A dichotomous (yes or no) classification of the results of both provocative tests (positive and negative) and coronary angiography (disease present or absent) in conventional sensitivity/specificity analysis of test results has at least three important limitations. Coronary artery disease is not an all or none condition: a binary classification requires arbitrary threshold criteria and creates artificial distinctions in coronary artery disease, which, in actuality, shows a continuum spectrum of severity [1]. Sensitivity and specificity values tend to be affected by the disease distribution in the study population: a sample distribution with a high frequency of mild disease will be placed centrally near the threshold values, where scatter is more likely to lower sensitivity and specificity [2]. Percentage of diameter narrowing is not an adequate standard to quantifying stenosis severity in clinical studies [3]: in unselected populations, this anatomic parameter has a poor correlation with the coronary flow reserve (see Chap. 3). Thus, coronary artery disease is a complex phenomenon which cannot be described adequately by means of a simple “normality vs disease” code; there are, in fact, significant differences as regards the degree and the extent of coronary artery disease, carrying important implications for both the therapeutic and the prognostic side. A stress test should then not only predict the presence/absence of coronary disease, but also stratify the disease severity. Accordingly, the diagnosis of myocardial ischemia by stress echocardiography should be delimited by time/space coordinates which represent: the circumferential (horizontal) extent of ischemia (x axis); the transmural (vertical) depth of ischemia (y axis); the ischemia-free stress time (i.e., the time from the start of the stress to the appearance of ischemia) (z axis) (Fig. 1).
“If time and space, as sages say/are things that cannot be the butterfly that lives a day/has lived as long as we ... ... but time is time, and passes by/though sages disagree”
T. S. Eliot, Song
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Demer LL, Gould LK, Goldstein RA, Kirkeeide RL, Mullani NA, Smalling RW, Nishikawa A, Merhige ME (1989) Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. Circulation 79:825–835
Hlatky MA, Mark DB, Harrell FE, Lee KL, Califf RM, Pryor DB (1987) Rethinking sensitivity and specificity. Am J Cardiol 59:1195 — 1198
Marcus ML, Skorton DJ, Johnson MR, Collins SM, Harrison DG, Kerber RE (1988) Visual estimates of percent diameter coronary stenosis: a battered gold standard. J Am Coll Cardiol 11:882–885
Sawada SG, Segar DS, Ryan T et al (1991) Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 83:1605 —1614
Iliceto S, Sorino M, D’Ambrosio G et al (1985) Detection of coronary artery disease by two-dimensional echocardiography and transesophageal atrial pacing. J Am Coll Cardiol 5:1188–1197
Marcowitz P, Armstrong WF (1992) Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol 69:1269–1273
Marwick T, D’Hondt A, Baudhuin T et al (1993) Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography, scintigraphy or both? J Am Coll Cardiol 22:159— 167
Armstrong WF, O’Donnell J, Ryan T, Feigenbaum H (1987) Effect of prior myocardial infarction and extent and location of coronary disease on accuracy of exercise echocardiography. J Am Coll Cardiol 10:531–538
Bolognese L, Sarasso G, Bongo AS et al (1991) Dipyridamole echocardiography test. A new tool for detecting jeopardized myocardium after thrombolytic therapy. Circulation 84:1100–1106
Berthe C, Pierard LA, Hiernaux M et al (1986) Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol 58:1167 — 1172
Jaarsma W, Visser CA, Funke Kupper AJ et al (1986) Usefulness of two-dimensional exercise echocardiography shortly after myocardial infarction. Am J Cardiol 57:86 —90
Bolognese L, Sarasso G, Aralda D, Bongo A, Rossi L, Rossi P (1989) High-dose dipyridamole-echocardiography early after uncomplicated myocardial infarction: correlation with exercise testing and coronary angiography. J Am Coll Cardiol 14:357 —362
Sheffield LT (1980) Exercise stress testing. In: Braunwald E (ed) Heart disease. A textbook of cardiovascular medicine. WB Saunders, Philadelphia
Armstrong WF (1988) Exercise echocardiography: ready, willing and able. J Am Coll Cardiol 11:1359–1361
Crouse LJ, Harbrecht JJ, Vacek JL, Rosamond TL, Kramer PH (1991) Exercise echocardiography as a screening test for coronary artery disease and correlation with angiography. Am J Cardiol 67:1213–1218
Ryan T, Segar DS, Sawada SG et al (1993) Detection of coronary artery disease with upright bicycle exercise echocardiography. J Am Soc Echo 6:186–197
Sheikh KH, Bengtson JR, Helmy S et al (1990) Relation of quantitative coronary lesion measurements to the development of exercise-induced ischemia assessed by exercise echocardiography. J Am Coll Cardiol 15:1043 —1051
Segar DS, Brown SE, Sawada SG, Ryan T, Feigenbaum H (1992) Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 19:1197–1202
Baptista J, Arnese M, Fioretti P, Keane D, Escanded J, Boersma, Di Mario C, Serruys P (1994) Quantitative coronary angiography in the estimation of the functional signifi
cance of a coronary stenosis. Correlations with dobutamine-atropine stress test. J Am Coll Cardiol 23:1434—1440
Amico A, Iliceto S, D’Ambrosio G, Sorino M, Coluccia P, Rizzon P (1987) Evaluation of timing of occurrence of wall motion abnormalities during incremental atrial pacing aids in the prediction of the severity of coronary artery disease. Eur Heart J 8:190 —194
Picano E, Parodi 0, Lattanzi F, Sambuceti G, Andrade MJ, Marzullo P, Giorgetti A, Salvadori P, Marzilli M, Distante A (1994) Assessment of anatomic and physiologic severity of single-vessel coronary artery lesions by dipyridamole echocardiography: comparison with positron emission tomography and quantitative arteriography. Circulation 89:753—761
Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A (1987) Different degrees of ischemic threshold stratified by dipyridamole-echocardiography test. Am J Cardiol 59:71 — 73
Picano E, Severi S, Michelassi C, Lattanzi F, Masini M, Orsini E, Distante A, L’Abbate A (1989) Prognostic importance of dipyridamole-echocardiography test in coronary artery disease. Circulation 80:450 — 457
Lattanzi F, Picano E, Bolognese L, Piccinino C, Sarasso G, Orlandini A, L’Abbate A (1991) Inhibition of dipyridamole-induced ischemia by antianginal therapy in man: correlation with exercise-electrocardiography. Circulation 83:1256 —1262
Ferrara N, Longobardi G, Nicolino A et al (1992) Effect of beta-adrenoreceptor blockade on dipyridamole-induced myocardial asynergies in coronary artery disease. Am J Cardiol 70:724 —727
Fioretti P, Poldermans D, Salustri A, Forster T, Boersma E, McNeill AJ, El-Said EM, Roelandt JRTC (1994) Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta blockers. Eur Heart J 15:355–360
Marwick T, Stewart WJ, Salcedo EE (1992) Diagnosis of coronary artery disease using exercise echocardiography and positron emission tomography: comparison and analysis of discrepant results. J Am Soc Echo 5:231–238
Picano E, Pirelli S, Marzilli M, Faletra F, Lattanzi F, Campolo L, Massa D, Alberti A, Gara E, Distante A, LAbbate A (1989) Usefulness of high-dose dipyridamole echocardiography test in coronary angioplasty. Circulation 80:807 –815
Kahn JK, McGhie I, Akers MS et al (1989) Quantitative rotational tomography with 201-TI and 99m-Tc 2-methoxy-isobutyl-isonitrile. A direct comparsion in normal individuals and patients with coronary artery disease. Circulation 79:1282 —1290
Sawada SG, Judson WE, Ryan T, Armstrong WF, Feigenbaum H (1989) Upright bicycle exercise echocardiography after coronary artery bypass grafting. Am J Cardiol 64:1123—1129
Crouse LJ, Vacek JL, Beauchamp GD, Porter CB, Rosamond TL, Kramer PH (1992) Exercise echocardiography after coronary artery bypass grafting. Am J Cardiol 70:572— 576
Fioretti PM, Pozzoli MMA, Ilmer B et al (1992) Exercise echocardiography versus thallium-201 SPECT for assessing patients before and after PTCA. Eur Heart J 13:213–219
McNeill AJ, Fioretti PM, El-Said EM, Salustri A et al (1992) Dobutamine stress echocardiography before and after coronary angioplasty. Am J Cardiol 69:740–745
Lombardi M, Morales MA, Michelassi C, Moscarelli E, Distante A, L’Abbate A (1993) Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischemia. A double-blind placebo-controlled study. Eur Heart J 14:845–852
Picano E, Lattanzi F, Distante A, LAbbate A (1989) Role of myocardial oxygen consumption in dipyridamole-induced ischemia. Am Heart J 118:314–319
Picano E, Marini C, Pirelli S, Maffei S, Bolognese L, Chiriatti GP, Chiarella F, OrIandini A, Seveso G, Quarta Colosso M, Scalvo MG, Magaia 0, Agati L, Previtali M, Lowenstein J, Torre F, Rosselli P, Ciuti M, Ostojic M, Gandolfo N, Margaria F, Giannuzzi P, Di Bello V, Lombardi M, Gigli G, Ferrara N, Santoro F, Lusa AM, Chiarandà G, Papagna D, Coletta C, Boccardi L, De Cristofaro M, Papi L, Landi P. on behalf of the EPIC study group (1992) Safety of intravenous high-dose dipyridamole echocardiography. Am J Cardiol 70:252— 256
Poldermans D, Fioretti PM, Boersma E, Forster T, van Urk H, Cornel JH, Arnese M, Roelandt JRTC (1994) Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease: experience in 650 consecutive examinations. Am J Cardiol 73:456 — 459
Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J, Feigenbaum H (1993) Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 88:15 —19
Pingitore A, Reisenhofer B, Chiarandà S, Mattioli R, Bellotti P, Previtali M, Quartacolosso M, Gigli G, Bigi R, Heymann J, Garyfallidis X, Picano E, on behalf of the Echo Dobutamine Italian Study Group (1992) Safety of dobutamine-atropine echocardiography: preliminary results of a multicenter trial. Circulation [Suppl] 86:1 —128
Mazieka PK, Nadazdin A, Oakley CM (1992) Clinical significance of abrupt vasodepression during dobutamine stress echocardiography. Am J Cardiol 69:1484–1847
Marcowitz PA, Bach DS, Mathias W, Shayna V, Armstrongs WF (1994) Paradoxic hypotension during dobutamine stress echocardiography: clinical and diagnostic implications. J Am Coll Cardiol 21:1080–1086
Pellikka PA, Oh JK, Bailey KR, Nichols BA, Monahan KH, Tajik AJ (1992) Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation. Circulation 86:1429–1432
Heinle SK, Tice FS, Kisslo J (1994) Left ventricular outflow obstruction and hypotensive response during dobutamine stress echocardiography: is there a relationship? J Am Coll Cardiol 233:143A
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Picano, E. (1994). Grading of Ischemic Response in Stress Echocardiography. In: Stress Echocardiography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02979-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-02979-4_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-02981-7
Online ISBN: 978-3-662-02979-4
eBook Packages: Springer Book Archive